5545850
Tocris Bioscience™ KRCA 0008
Potent Ack1 and ALK dual inhibitor; orally bioavailable
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Purity
>99%
Product Type
KRCA 0008
Molecular Weight (g/mol)
609.12
Inhibitors
KRCA 0008
Related Products
Description
- Potent Ack1 and anaplastic lymphoma kinase (ALK) dual inhibitor (IC50 values are 4 and 12 nM respectively)
- Inhibits lung cancer H3122 cell proliferation (IC50 = 80 nM)
- Attenuates H3122 cell xenograft tumor growth in mice
- Orally bioavailable.
Compare Similar Items
Show Difference
Purity: >99%
Product Type: KRCA 0008
Molecular Weight (g/mol): 609.12
Inhibitors: KRCA 0008
Purity:
>99%
Product Type:
KRCA 0008
Molecular Weight (g/mol):
609.12
Inhibitors:
KRCA 0008
Purity: >98%
Product Type: LDN 209929 dihydrochloride
Molecular Weight (g/mol): 405.77
Inhibitors: LDN 209929 dihydrochloride
Purity:
>98%
Product Type:
LDN 209929 dihydrochloride
Molecular Weight (g/mol):
405.77
Inhibitors:
LDN 209929 dihydrochloride
Purity: 0.98
Product Type: Licarbazepine
Molecular Weight (g/mol): 254.28
Inhibitors: Licarbazepine
Purity:
0.98
Product Type:
Licarbazepine
Molecular Weight (g/mol):
254.28
Inhibitors:
Licarbazepine
Purity: 95%
Product Type: LM11A 31 dihydrochloride
Molecular Weight (g/mol): M.W. (Observed): 316.27
Inhibitors: LM11A 31 dihydrochloride
Purity:
95%
Product Type:
LM11A 31 dihydrochloride
Molecular Weight (g/mol):
M.W. (Observed): 316.27
Inhibitors:
LM11A 31 dihydrochloride